Reviewed by Michael Gill, B. Sc.
2 Primary Immune Deficiency Clinical Trials Near Me
Top Hospitals for Primary Immune Deficiency Clinical Trials
Image of Houston Methodist Hospital in Texas.
Houston Methodist Hospital
Houston
1Active Trials
1All Time Trials for Primary Immune Deficiency
2022First Primary Immune Deficiency Trial
Image of Texas Children's Hospital in Texas.
Texas Children's Hospital
Houston
1Active Trials
3All Time Trials for Primary Immune Deficiency
2007First Primary Immune Deficiency Trial
Top Cities for Primary Immune Deficiency Clinical Trials
Image of Houston in Texas.
Houston
2Active Trials
Houston Methodist HospitalTop Active Site
Image of St. Petersburg in Florida.
St. Petersburg
1Active Trials
University of South FloridaTop Active Site
Primary Immune Deficiency Clinical Trials by Phase of Trial
N/A Primary Immune Deficiency Clinical Trials
2Active Primary Immune Deficiency Clinical Trials
2Number of Unique Treatments
1Number of Active Locations
Primary Immune Deficiency Clinical Trials by Age Group
< 65 Primary Immune Deficiency Clinical Trials
1Active Primary Immune Deficiency Clinical Trials
Most Recent Primary Immune Deficiency Clinical Trials
Top Treatments for Primary Immune Deficiency Clinical Trials
Treatment Name
Active Primary Immune Deficiency Clinical Trials
All Time Trials for Primary Immune Deficiency
First Recorded Primary Immune Deficiency Trial
CliniMACS
1
1
2022
Bacteriophage
1
1
1995
Recently Completed Studies with FDA Approved Treatments for Primary Immune Deficiency
Treatment
Year
Sponsor
IGSC 20%
2021
Grifols Therapeutics LLC
IVIG-PEG
2020
Grifols Therapeutics LLC
CUTAQUIG
2019
Octapharma
HYQVIA
2017
Baxalta now part of Shire

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 28th, 2021

Last Reviewed: November 9th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.